In this episode of the Huberman Lab podcast, Huberman speaks with Dr. Max Krummel about how the immune system functions as a sophisticated sensory network that extends far beyond fighting infections. Krummel explains how immune cells constantly monitor the body, distinguishing self from non-self, and perform essential maintenance roles in organs like the brain, gut, and liver. The conversation covers immune system development from infancy through aging, including why the thymus shrinks over time and how this affects susceptibility to disease.
The episode also explores the connections between the nervous system and immune function, including how sleep, stress, and even mindset can influence immune responses. Krummel and Huberman discuss vaccine hesitancy, emphasizing the importance of transparent scientific communication and individualized risk-benefit discussions. Finally, they examine advances in cancer immunotherapy and the challenges of developing precision medicine, highlighting how economic incentives can sometimes work against patient-specific treatments.

Sign up for Shortform to access the whole episode summary along with additional materials like counterarguments and context.
The immune system functions as a vast sensory network, with an estimated 100 billion unique T cells constantly sampling proteins and peptides throughout the body. Each T cell acts as a mobile sensor, helping to curate what is recognized as "self" and initiating action against anything deemed outside acceptable ranges. These immune cells are highly dynamic, traveling through blood and lymphatics to monitor all tissues, with some resident in specific organs for localized surveillance.
Using advanced imaging, researchers have witnessed immune cells actively crawling within tissues, forming clusters and communicating via synapse-like connections similar to neurons. When encountering a potential threat, cells can share information and collectively decide whether an immune response is necessary.
The system's primary challenge is discriminating self from non-self. Using a World War II submarine analogy, immune cells rely on an internal reference—like a book of familiar "engine sounds"—to avoid attacking self while remaining ready to fire on "foreign engines," the molecular signatures of pathogens. Over time, the immune system learns these patterns, retaining memory to respond faster upon re-exposure while developing tolerance to persistent self-proteins.
The immune system's roles extend far beyond fighting infections. In the brain, specialized immune cells called microglia perform cleanup functions and maintain neural health. In the gut, immune cells regulate beneficial bacteria essential for digesting certain foods and nutrient absorption. Immune cells in the liver contribute to metabolic regulation, while those in the heart help clean up byproducts from heart muscle cells.
Historically, immunology viewed responses as binary—"on" for foreign invaders or "off" for self. Cancer immunotherapy research shifted this perspective, revealing that immune responses are tunable and context-dependent. The immune system can now be seen as capable of a spectrum of actions, from tolerance to targeted elimination, constantly collecting and processing information to maintain balance.
The thymus produces and educates T cells to prevent autoimmunity. Stem cells from bone marrow travel to the thymus, where they're presented with molecular signatures from the self-genome. The thymus trains developing T cells, eliminating those that react too strongly to self while allowing properly tuned cells to enter circulation.
The thymus is especially active during early childhood, when the immune system transitions from maternal protection to independence, outputting vast numbers of new T cells essential for developing robust immunity. However, as humans age, the thymus shrinks dramatically—a process known as involution—resulting in fewer new T cells later in life. This potentially results from evolutionary pressures favoring immune vigor only through reproductive years. Because of its central role, the thymus has become a target for therapies aimed at restoring immune function, particularly in aging or cancer.
For the first six months of life, newborns exhibit suppressed immune responses, essential because the rapidly developing body could otherwise provoke mistaken immune attacks against itself. This developmental immunosuppression explains why several childhood vaccinations are scheduled after six months, when the immune system is better positioned to generate safe, lasting immunity.
During the first ten years, children often catch frequent illnesses because each pathogen they encounter is novel. Symptoms like fever typically indicate immune mobilization rather than failure. During this period, children also build a diverse microbiome, with the immune system learning to distinguish between harmful pathogens and beneficial commensals. This balance allows beneficial bacteria to perform vital functions while maintaining defenses against invaders.
Over decades, every cell accrues mutations through normal replication and environmental exposures. Skin cells, for example, may accumulate 10,000–30,000 mutations per cell per day. The body becomes a biological mosaic, with each cell harboring unique genetic changes. As this mosaic grows more complex with age, the immune system's ability to distinguish "self" from "other" becomes confused, making viral proteins or precancerous molecules harder to detect.
Compounding this issue, the shrinking thymus produces fewer new T cells, depriving the aging immune system of fresh soldiers and making older adults more susceptible to infections and cancers. With age and accumulating mutations, cancer risk rises. One visible sign of ongoing immune surveillance is the appearance of small white spots in aging skin—areas where potentially precancerous pigmented cells have been recognized and eliminated by immune cells.
Children and young adults heal wounds quickly because they host abundant stem and progenitor cells poised to rapidly replicate and replace lost tissue. However, the same biological processes that enable quick wound healing also bring latent cancer risk, as mutations that speed up cell division are favored for healing but can tip toward uncontrolled growth. This represents an inherent trade-off between youthful tissue repair and long-term safety.
Max Krummel describes how, during sleep, immune cells such as neutrophils clear back to the bone marrow, and tissues become populated with fresh neutrophils that aid in repair. Many immune cells go quiescent in tissues during sleep, pausing their responses to enable reparative processes. Krummel likens the body to a high-energy machine accumulating biological byproducts during waking hours, with sleep allowing a "cleanup phase" that reduces metabolic byproducts and repairs oxidative damage. He gives the analogy of macrophages continually cleaning the eye's lens, most effectively during sleep when the body isn't exposed to new antigens.
Krummel highlights emerging research showing that the insular cortex can program immune states in organs via neural pathways such as the vagus nerve. In mouse studies, neurons in the insular cortex activated during gut inflammation could, when reactivated later, prompt a return to inflammation—even without the original trigger. The insular cortex is involved in moral decision-making, empathetic pain, and learning from sensory experiences, acting as a hub linking cognitive, sensory, and immune processes.
Research suggests that practices like meditation and breath control may allow individuals to consciously reset inflammation by modulating the insular cortex and autonomic nervous system. Andrew Huberman notes that what once seemed speculative is now substantiated by studies linking mind-body techniques to improved immune function.
Acute stress releases hormones that temporarily boost immune function, adaptive for immediate survival threats. However, chronic stress leads to persistent hormone elevation, which suppresses the immune system. The immune system forms memory-like associations via the nervous system, with sensory cues and contexts tied to past immune responses later re-evoking those same states. Positive experiences and supportive relationships enhance immune response, while chronic loneliness or negativity suppresses immunity.
Huberman observes that some people never seem to get sick while others frequently fall ill, which may reflect self-perpetuating neural-immune communication patterns. Those who believe they get sick often may trigger or maintain immune states through their mindset, while those with a resilient mindset may unconsciously foster healthier immune signaling. This interplay blurs the boundaries between brain, immune system, and perception.
Huberman describes vaccine hesitancy as a nuanced spectrum. Many people are not ideologically opposed to vaccines but are questioners who want clearer answers regarding timing, doses, and schedules. He acknowledges that skepticism is not necessarily unfounded, especially considering historic medical traumas and injustices that have fostered generational distrust in authorities and the medical system. The sense of pharmaceutical companies having legal protections against vaccine injury lawsuits heightens frustration, especially among parents who observe adverse effects and feel left without recourse.
Both Krummel and Huberman assert that standard childhood vaccination protocols were often chosen for logistical or financial convenience rather than through extensive study of alternative schedules. Krummel emphasizes the need for research into alternative vaccination schedules, suggesting clear and publicly available comparative studies where individuals could choose between regimens. However, these studies are not currently prioritized, largely because the logistics of deviation from protocol present challenges.
Both speakers stress that communicating science transparently and with nuance is essential for public trust. The COVID-19 pandemic highlighted failures in public health communication, where data scarcity early on led to rapidly evolving and sometimes conflicting messages. Presenting uncertain data as definitive fact harmed scientific credibility. They call for scientists and health officials to openly share what studies have been done, admit where uncertainties remain, and engage in clear, contextual, risk-benefit discussions tailored to individual concerns.
Vaccine hesitancy is frequently context-dependent rather than blanket science rejection. Krummel highlights that patients who may resist recommended childhood vaccines often reconsider in the face of terminal illnesses, such as cancer, showing that hesitancy stems from attempts to weigh risks and benefits. Advancing public health requires understanding these contextual motivators and fostering open, individualized dialogue.
Immunotherapies are transforming cancer treatment by achieving cures in previously untreatable cases. One key development has been targeting inhibitory molecules on T cells that tumors exploit to suppress immune attacks. By blocking these molecules, immune cells are unleashed to target cancer, sometimes curing up to 50% of previously untreatable melanomas. This demonstrates that the immune system is not binary but functions as a tunable system, with reactivity adjustable along a spectrum.
Humans possess remarkable biological resilience, with multiple redundant pathways maintaining stability. Consequently, most diseases, especially cancers, cannot be overcome by a single intervention. Effective treatment often requires sequential changes: disarming tumor-driven defenses, shifting immune states, and finally activating tumor-killing immunity. Most progress arises through a series of targeted nudges that overcome the system's layered barriers.
Emerging therapies now account for spatial variation and context within tissues, as cellular signaling differs profoundly across anatomical zones. Effective therapies require not just the right agents but delivery to the correct tissue region with precise timing and dose.
Machine learning now allows researchers to profile all cell types in a tumor, analyze gene expression, and map cellular interactions. These models can predict how altering molecules might impact the system. However, machine learning makes connections only within already known data and cannot generate truly novel concepts. Human judgment remains essential in designing and interpreting experiments.
Technologies like umbilical cord banking and induced pluripotent stem cell therapies capture the imagination but bring open questions. While cord banking offers a non-invasive source of stem cells potentially lifesaving for children with leukemia, the actual number of people who have survived solely because of it is unclear. Attempts to store thymic tissue or use iPSC technology for organ regeneration face hurdles of unknown genetic mutations, immune rejection, and technical limits.
Current economic incentives discourage pharmaceutical companies from developing tests to identify which patients will benefit from new drugs. Even if only 50% of patients respond to a given therapy, the lack of a predictive test ensures every patient is prescribed the drug, maximizing profits. Unless profits are decoupled from the number of prescriptions written, industry will remain reluctant to develop precision tools, highlighting the need for policy changes to incentivize patient-specific treatments.
1-Page Summary
For decades, immunologists have worked to understand the complexity of immune cells and their behaviors. Each T cell functions like a mobile sensor, constantly sampling the concentration of specific proteins and peptides throughout the body. With an estimated 100 billion unique T cell sensors, the immune system works continuously to curate what is recognized as “self” and initiates action against anything deemed out of acceptable range.
Immune cells are dynamic and highly migratory, traveling through blood and lymphatics to monitor all tissues. Some immune cells are resident in specific organs, providing localized surveillance and support. Using advanced imaging, researchers have witnessed these immune cells actively crawling within tissues, forming clusters and communicating via synapse-like connections similar to neurons. When a cell encounters a potential threat, it can share information with other immune cells, collectively deciding whether an immune response is necessary.
The immune system's primary challenge is discriminating self from non-self. As explained with a World War II submarine analogy, immune cells rely on an internal reference, like a book of familiar “engine sounds,” to avoid attacking self while remaining ready to fire on “foreign engines”—the molecular signatures of pathogens. This fine discrimination allows immune cells to ignore long-present molecules found in the body, such as [restricted term], while rapidly reacting to new, abnormally-spiking proteins characteristic of viral infections or abnormal cells.
Over time, the immune system “learns” these non-self patterns. If a virus appears, T cells detecting it respond aggressively, and upon clearing the virus, retain memory to respond faster if it returns. Meanwhile, persistent exposure to self-proteins leads to immune tolerance, as cells adjust to long-standing molecular ranges and only react if levels change drastically or abnormally.
The immune system’s roles extend far beyond pathogen defense—it participates in organ maintenance, nutrient absorption, and homeostatic regulation throughout the body.
In the brain, specialized immune cells called microglia perform cleanup functions, removing debris and maintaining neural health. In the gut, immune cells regulate the balance of beneficial bacteria, allowing symbiotic microbes to thrive while preventing harmful overgrowth. This bacterial regulation is essential, as gut microbes are necessary for digesting certain foods—such as animal fats and seaweed—and help in nutrient absorption.
Immune cells in the liver contribute to metabolic regulation. In the heart, they help clean up byproducts created by cardiomyocytes (heart muscle cells), supporting heart health and functional stability. Collectively, nearly every organ maintains populations of immune cells dedicated to local surveillance and continuous monitoring.
Historically, immunology viewed responses as a binary switch—“on” for foreign invaders or “off” for self. Cancer immunotherapy research shifted this perspective, showing that immune responses are tunable. Tumors, for example, are abnormal “self” but not outright foreign, requiring the immune system to fine-tune its reactivity threshold. The immune system can now be seen as context-dependent, capable of a spectrum of actions: from tolerance, to the quarantining of microbes, to targeted elimination. It constantly collects and processes information to maintain balance, rather than simply flipping between quiescence and activation.
Immune System Fundamentals
Immune function is not static but shifts through distinct phases, each with specific advantages and vulnerabilities. Early immune suppression, pediatric adaptation and diversification, and eventual decline in immune vigilance collectively shape lifelong health and disease risk.
For the first six months of life, newborns exhibit a suppressed immune response. This is essential because the rapidly developing body could otherwise provoke mistaken immune attacks against itself. As new genes turn on during development, a hyperactive immune system might misidentify these transient novel proteins as threats, leading to autoimmunity. This developmental immunosuppression also explains why several childhood vaccinations are scheduled after six months—when the immune system is better poised to generate safe, lasting immunity.
During the first ten years, children often seem to catch frequent illnesses. This is because each virus or bacterium they encounter is novel, requiring the immune system to “learn” these threats for the first time. Symptoms like fever or malaise are usually signs that the immune system is mobilizing rather than failing. Although children may suffer repeated minor infections, their immune responses are typically robust and effective, except in the case of rare, particularly dangerous pathogens (such as mumps or measles), which is why immunization is essential to prevent severe disease.
In early life, children also build a highly diverse microbiome. As infants and young children encounter a vast array of environmental microbes—on their skin, in their gut, and in the air—the immune system undergoes training to distinguish between harmful pathogens and beneficial commensals. This detente allows beneficial bacteria to perform vital functions, such as helping digest complex food components like seaweed or generating essential bile acids for fat digestion, while antimicrobial defenses still fire against invaders. The development of tolerance alongside readiness to fight pathogens is a delicate balance that establishes long-term health.
Over decades, every cell in the body accrues mutations through normal DNA replication, environmental exposures (like UV sunlight on skin), and cellular division. Skin cells, for example, may accumulate 10,000–30,000 mutations per cell per day. Different organs accrue mutations at their own rates. Consequently, the body becomes a biological mosaic, with each cell harboring a unique set of genetic changes. These cellular variations become especially pronounced with age, so tissues are not uniform, but rather comprise a patchwork of clones, each with its own subtle differences.
As this genetic mosaic grows denser and more complex in older age, the immune system’s ability to distinguish “self” from “other” becomes confused. With so many subtly mutated cells, the range of what qualifies as “self” expands. Viral proteins or precancerous molecules may be harder to detect among this noise, since rogue or abnormal cells don't stand out as clearly against the background of normal variation.
Compounding this issue, the thymus—a specialized organ responsible for producing new T cells—shrinks dramatically with age. In children, thymic tissue is abundant and active, but by late adulthood, it is tiny and produces few, if any, new T cells. This deprives the aging immune system of fresh soldiers, making older adults more susceptible to infections and cancers alike.
With age and accumulating mutations, the risk of cancer rises. The immune system prunes incipient cancers, and one visible sign of this ongoing battle is the appearance of small white spots in the skin of people over 40 or 50. These spots are areas where pigmented (melanocyte) cells—potentially precancerous—have been recognized and eliminated by immune cells. This white patchwork is physical evidence of immunosurveillance against early cancer.
Healing and tissue ...
Immune Function Across the Lifespan
The interplay between the nervous system and the immune system—neuroimmune modulation—reveals how sleep, stress, brain regions, and mindset can shape immune function. Recent research and analogies illuminate the deeply interwoven biology of body and mind.
Max Krummel describes how, during sleep, immune cells such as neutrophils clear back to the bone marrow, and tissues become populated with fresh neutrophils that aid in repair, such as depositing collagen around the body. Many immune cells go quiescent in tissues during sleep, pausing their responses to enable reparative processes. This period of rest allows tissues to restore themselves uninterrupted by active immune defense, supporting systemic healing.
Krummel likens the body to a high-energy machine accumulating biological byproducts and oxidative damage during waking hours. Sleep allows the body to reset by initiating a “cleanup phase,” reducing metabolic byproducts and repairing oxidative damage. The immune system, too, undergoes resetting at night, ensuring it can effectively defend against future threats.
Krummel gives the analogy of macrophages—immune cells in the eye—continually cleaning the lens, similar to washing a windshield. This cleaning is most effective during sleep, when the body isn’t being exposed to new antigens (like a windshield not hit by new flies), allowing immune cells to clear debris without interference. This restful period ensures the immune system can properly maintain tissues.
Krummel highlights emerging research showing that the insular cortex can program immune states in organs via neural pathways such as the vagus nerve. In a mouse study, neurons in the insular cortex activated during gut inflammation, when reactivated later, prompted a return to inflammation in the gut—even without the original trigger. Thus, neural patterns alone can recall immune states.
The insular cortex is involved in moral decision-making, empathetic pain, and learning from sensory experiences—for example, witnessing someone’s injury and feeling pain oneself. This brain region acts as a hub linking cognitive, sensory, and immune processes, supporting the notion that thoughts and learned associations can shape immune responses.
Research suggests that practices like meditation and breath control may allow individuals to consciously reset inflammation by modulating the insular cortex and the autonomic nervous system. Meditation may communicate less inflammatory states throughout the body by transmitting calming signals, harnessing the neural-immune axis. Huberman notes that what once seemed speculative is now substantiated by studies linking mind-body techniques to improved immune function.
Acute stress releases hormones that temporarily boost immune function, which is adaptive for immediate survival threats. However, chronic stress leads to persistent hormone elevation, which suppresses the immune system and increases vulnerability to illness.
The immune system forms memory-like associations via the nervous system. Sensory cues and contexts tied to past immune responses can later re-evoke those same states, similar to how the brain encodes and retrieves emotional or sensory memories.
Neuroimmune Modulation
Vaccine hesitancy remains a complex and persistent issue, even in the face of the medical success of vaccines. Andrew Huberman describes vaccine hesitancy as a nuanced spectrum. Many people are not ideologically opposed to vaccines but are instead questioners who want clearer answers regarding timing, doses, and vaccine schedules for their children. These people do not reject vaccines outright but wonder whether spacing out doses or changing the schedule might still offer effective protection.
Huberman notes that skepticism is not necessarily unfounded, especially considering historic medical traumas and injustices that have fostered generational distrust in authorities and the medical system. He acknowledges a deep-seated loss of legitimacy for pharmacological and medical institutions, partly due to the aggressive advertising of drugs with severe side effects, sometimes perceived as worse than the symptoms they intend to treat. This skepticism toward pharmaceutical companies spills over onto vaccines, despite the difference in their risk-benefit profiles. The sense of pharmaceutical companies having legal protections against vaccine injury lawsuits only heightens frustration, especially among parents who observe adverse effects in their children and feel left without recourse.
Max Krummel and Andrew Huberman both assert that standard childhood vaccination protocols were not always devised through extensive study of alternative schedules. Instead, these protocols were often chosen for logistical or financial convenience; regimented protocols reduce the chances of missed doses and streamline healthcare delivery. Krummel gives a personal example of delaying his daughter's vaccine by a month due to illness and points out that, based on his research experience, spacing vaccinations differently may still lead to the same protective outcomes.
Krummel emphasizes the need for research into alternative vaccination schedules or combining vaccines into fewer shots, suggesting clear and publicly available comparative studies where individuals could choose between regimens. However, these studies are not currently prioritized, largely because the logistics of deviation from protocol present challenges for both healthcare providers and patients. The protocols persist mainly for convenience and because, statistically, they have proven generally safe and effective, but this doesn’t preclude the possibility of optimizing or customizing them further.
Both Huberman and Krummel stress that communicating science transparently and with nuance is essential for public trust. The COVID-19 pandemic highlighted failures in public health communication: data scarcity early in the pandemic led to rapidly evolving—and sometimes conflicting—messages about transmission, safety, and interventions. Presenting uncertain or incomplete data as definitive fact harmed scientific credibility and eroded public trust. Huberman argues that the approach of having a single authoritative spokesperson, rather than a nuanced scientific panel, contributed to these issues. Social shaming and mandate-driven communication only deepened polarization and further diminished confidence.
Krummel and Huberman warn that the public must understand protocols reflect current best practices informed by available eviden ...
Vaccines, Public Communication of Science, and Vaccine Hesitancy
Recent breakthroughs in immunotherapies, especially for cancer, are transforming perspectives on what is possible in disease treatment. Yet, the complexity and resilience of biological systems, the role of context, and the challenges of technology adoption ensure that future therapies will require ongoing, multi-faceted innovation and societal adaptation.
Immunotherapies are generating excitement by achieving cures in cancer—something rarely possible in the past. One key development has been targeting inhibitory molecules on T cells that elevate the activation threshold, a mechanism that tumors exploit to suppress immune attacks. By blocking these molecules, immune cells previously held in check are unleashed to target cancer, sometimes curing up to 50% of previously untreatable melanomas.
This success demonstrates the immense capability of the immune system to eliminate large, entrenched tumors when its activation threshold is precisely tuned. The crucial breakthrough is recognizing that the immune system is not binary but functions as a tunable system. Rather than simply being "off" or "on," immune reactivity can be adjusted along a spectrum, offering strategic opportunities for therapy.
Humans are remarkably resilient; we can tolerate extreme environmental stress and survive substantial physiological insults. This resilience extends to our biological systems, which have evolved multiple redundant and overlapping pathways to maintain stability. Consequently, most diseases, especially cancers, cannot be overcome by a single intervention.
For effective treatment, particularly in complex diseases, it’s often necessary to induce sequential changes. Like moving a "fuel gauge" from low to high immune reactivity, the process may require several steps: first disarming tumor-driven inflammatory defenses, then shifting the immune state so an attack can succeed, and finally activating tumor-killing immunity. Dramatic results from "one-and-done" drugs are rare; most progress arises through a series of targeted nudges that overcome the system's layered barriers.
Emerging therapies now account for spatial variation and context within tissues. Cellular signaling differs profoundly across even small anatomical zones, as seen in wound healing: cells near the site perform different functions than those farther away. Effective therapies, therefore, require not just the right agents but delivery to the correct tissue region with precise timing and dose, mirroring the ordered developmental signals that guide natural tissue formation.
Tissue engineering illustrates further challenges. If new genes are introduced into cells to manufacture organs for transplantation, the body may aggressively reject these as foreign, mistaking them for infected cells. Success in engineering new, functional tissues will demand solutions that overcome both tissue survival hurdles and immune acceptance.
Advances in machine learning now allow researchers to profile all the cell types in a tumor, analyze their gene expression, and map networks of cellular interactions. These models can predict how altering a particular molecule’s activity might impact the system. However, machine learning makes connections only within the realm of already known data. It does not generate truly novel concepts or identify completely unprecedented intervention ideas. Human judgment remains essential in designing, choosing, and interpreting experiments, especially when resources are limited and the decision of which predicted pathways to pursue can have substantial impact. Machine learning accelerates the hypothesis-generation process but cannot replace the creative and critical thinking of experienced scientists.
Technologies like umbilical cord banking and induced pluripotent stem cell (iPSC) therapies capture the imagination but bring open questions. Umbilical cords, typically discarded, ...
Novel Immunotherapies and Future Treatments
Download the Shortform Chrome extension for your browser
